Atlas Trials

Evaluation of the Unconformity of the Hormonal Status of Metastatic Lesions During a First Relapse of Breast Cancer Initially Expressing Estrogen Receptors: a Pilot Study on the Interest of PET With FES

Clinical trial NCT03873428 · UNKNOWN

Trial details

NCT number
NCT03873428
Sponsor
Centre Georges Francois Leclerc
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
FES TEP in Detection of Estrogen Receptors
Start date
2021-10-18
Primary completion
2025-10-18
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.